Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
Corresponding Author
G. M. Halliday Dr., PhD
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Department of Pathology, University of Sydney, N.S.W. 2006, AustraliaSearch for more papers by this authorY. W. Li MS
Department of Neuropathology, Institute of Medical and Veterinary Sciences, Adelaide, South Australia
Search for more papers by this authorP. C. Blumbergs FRCPA
Laboratory of Molecular Neurobiology, Cornell University Medical College, Ithaca, NY
Search for more papers by this authorT. H. Joh PhD
Murdoch Institute, Royal Childrens Hospital, Parkville, Victoria, South Australia, Australia
Search for more papers by this authorR. G. H. Cotton DSc
C.S.I.R.O. Division of Human Nutrition, Adelaide, South Australia, Australia
Search for more papers by this authorP. R. C. Howe PhD
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Search for more papers by this authorW. W. Blessing FRACP
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Search for more papers by this authorL. B. Geffen DPhil
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Search for more papers by this authorCorresponding Author
G. M. Halliday Dr., PhD
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Department of Pathology, University of Sydney, N.S.W. 2006, AustraliaSearch for more papers by this authorY. W. Li MS
Department of Neuropathology, Institute of Medical and Veterinary Sciences, Adelaide, South Australia
Search for more papers by this authorP. C. Blumbergs FRCPA
Laboratory of Molecular Neurobiology, Cornell University Medical College, Ithaca, NY
Search for more papers by this authorT. H. Joh PhD
Murdoch Institute, Royal Childrens Hospital, Parkville, Victoria, South Australia, Australia
Search for more papers by this authorR. G. H. Cotton DSc
C.S.I.R.O. Division of Human Nutrition, Adelaide, South Australia, Australia
Search for more papers by this authorP. R. C. Howe PhD
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Search for more papers by this authorW. W. Blessing FRACP
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Search for more papers by this authorL. B. Geffen DPhil
Centre for Neuroscience, Flinders Medical Centre, Bedford Park, South Australia
Search for more papers by this authorAbstract
Regional loss of immunohistochemically identified neurons in serial sections through the brainstem of 4 patients with idiopathic Parkinson's disease was compared with equivalent sections from 4 age-matched control subjects. In the Parkinson brains, the catecholamine cell groups of the midbrain, pons, and medulla showed variable neuropathological changes. All dopaminergic nuclei were variably affected, but were most severely affected in the caudal, central substantia nigra. The pontine noradrenergic locus ceruleus showed variable degrees of degeneration. There was also a substantial loss of substance P–containing neurons in the pedunculopontine tegmental nucleus. However, the most severely affected cell group in the pons was the serotonin-synthesizing neurons in the median raphe. In the medulla, substantial neuronal loss was found in several diverse cell groups including the adrenaline-synthesizing and neuropeptide Y–containing neurons in the rostral ventrolateral medulla, the serotonin-synthesizing neurons in the raphe obscurus nucleus, the substance P–containing neurons in the lateral reticular formation, as well as the substance P–containing neurons in the dorsal motor vagal nucleus. Lewy bodies were present in immunohistochemically identified neurons in many of these regions, indicating that they were affected directly by the disease process. These widespread but region- and transmitter-specific changes help account for the diversity of motor, cognitive, and autonomic manifestations of Parkinson''s disease.
References
- 1 Jellinger K. Overview of morphological changes in Parkinson's disease. Adv Neurol 1986; 45: 1–18
- 2 Mann DMA, Yates PO. Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol Appl Neurobiol 1983; 9: 3–19
- 3 Halliday GM, Blumbergs PC, Cotton RGH, et al. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 1989 (in press)
- 4 Pearson J, Goldstein M, Markey K, Brandeis L. Human brain stem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 1983; 8: 3–32
- 5 Kitahama K, Pearson J, Denoroy L, et al. Adrenergic neurons in human brain demonstrated by immunohistochemistry with antibodies to phenylethanolamine-N-methyltransferase (PNMT): discovery of a new group in the nucleus tractus solitarius. Neurosci Lett 1985; 53: 303–308
- 6 Haan EA, Jennings IG, Cuello AC, et al. A monoclonal antibody recognizing all three aromatic amino acid hydroxylases allows identification of serotonergic neurons in human brain. Brain Res 1987; 426: 19–27
- 7 Del Fiacco M, Dessi ML, Levanti MC. Topographical localization of substance P in the human post-mortem brainstem. An immunohistochemical study in the newborn and adult tissue. Neuroscience 1984; 12: 591–611
- 8 Hokfelt T, Lundberg JM, Lagercrantz H, et al. Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata. Neurosci Lett 1983; 36: 217–222
- 9 Halliday GM, Li YW, Joh TH, et al. Distribution of monoamine-synthesizing neurons in the human medulla oblongata. J Comp Neurol 1988; 273: 301-317
- 10 Halliday GM, Li YW, Oliver JR, et al. The distribution of neuropeptide Y-like immunoreactive neurons in the human medulla oblongata. Neuroscience 1988; 26: 179–191
- 11 Halliday GM, Li YW, Joh TH, et al. The distribution of substance P-like immunoreactive neurons in the human medulla oblongata, colocalization with monoamine-synthesizing neurons. Synapse 1988; 2: 353–370
- 12 Howe PRC, Costa M, Furness JB, Chalmers JP. Simultaneous demonstration of phenylethanolamine-N-methyltransferase immunofluorescent and catecholamine fluorescent nerve cell bodies in the rat medulla oblongata. Neuroscience 1980; 5: 2229–2238
- 13 Joh TH, Ross ME. Preparation of catecholamine synthesizing enzymes as immunogen for immunocytochemistry. In: AC Cuello, ed. Immunohistochemistry. International Brain Research Organization handbook series. Methods in the neurosciences, vol 3. Oxford: J. Wiley, 1983: 121–138
- 14 Blessing WW, Howe PRC, Joh TH, et al. Distribution of tyrosine hydroxylase and neuropeptide Y-like immunoreactive neurons in rabbit medulla oblongata, with attention to colocalization studies, presumptive adrenaline-synthesizing perikarya, and vagal pre-ganglionic neurons. J Comp Neurol 1986; 248: 285–300
- 15 Cuello AC, Galfre G, Milstein C. Detection of substance P in the central nervous system by a monoclonal antibody. Proc Natl Acad Sci USA 1979; 76: 3532–3536
- 16 De Armond SJ, Fusco MM, Dewey MM. Structure of the human brain. A photographic atlas. 2nd ed. New York: Oxford University Press, 1976
- 17 Haines DE. Neuroanatomy. An atlas of structures, section, and systems. Baltimore: Urban and Schwarzenberg, 1983
- 18 Olszewski J, Baxter D. Cytoarchitecture of the human brain stem. 2nd ed. Basel: Karger A.G., 1982
- 19 Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. Sydney: Academic Press, 1986
- 20 Dahlstrom A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the mammalian nervous system. I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta Physiol Scand [Suppl] 1964; 232: 1–55
- 21 Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988; 334: 345–348
- 22 German DC, Walker BS, Manaye K, et al. The human locus coeruleus: computer reconstruction of cellular distribution. J Neurosci 1988; 8: 1776–1788
- 23 Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 1987; 84: 5976–5980
- 24 Pakkenberg H, Brody H. The number of nerve cells in the substantia nigra in paralysis agitans. Acta Neuropathol (Berl) 1965; 5: 320–324
- 25 Togi H, Ogawa M, Yamanouchi M, et al. Quantitative studies of neurons of the substantia nigra and basal ganglia in parkinsonism. Clin Neurol 1976; 16: 311–318
- 26 Bogerts B, Hantsch J, Hertzer M. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients and schizophrenics. Biol Psychiatry 1983; 18: 951–969
- 27
Uhl GR,
Hedreen JC,
Price DL.
Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions.
Neurology
1985;
5: 1215–1218
10.1212/WNL.35.8.1215 Google Scholar
- 28 Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988; 51: 540–543
- 29 Zweig RM, Jankel WR, Hedreen JC, et al. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 1989; 26: 41–46
- 30 Eadie MJ. The pathology of certain medullary nuclei in parkinsonism. Brain 1963; 86: 781–795
- 31 Javoy-Agid F, Ruberg M, Hirsch E, et al. Recent progress in the neurochemistry of Parkinson's disease. In: S Fahn, ed. Recent developments in Parkinson's disease. New York: Raven Press, 1986: 67–83
- 32 Scatton B, Javoy-Agid F, Rouquier L, et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 1983; 275: 321–328
- 33 D'Amato RJ, Zweig RM, Whitehouse PJ, et al. Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol 1987; 22: 229–236
- 34 Scatton B, Dennis T, L' Heureux R, et al. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of Parkinsonian patients. Brain Res 1986; 380: 181–185
- 35 Vincent SR, Satoh K, Armstrong DM, Fibiger HC. Substance P in the ascending cholinergic reticular system. Nature 1983; 306: 688–691
- 36 Whitehouse PJ, Martino AM, Marcus KA, et al. Reductions in acetyl choline and nicotine binding in several degenerative diseases. Arch Neurol 1988; 45: 722–724
- 37 Woolf NJ, Butcher LL. Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res Bull 1986; 16: 603–637
- 38 Beninato M, Spencer RF. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res 1987; 412: 169–174
- 39 Mauborgne A, Javoy-Agid F, Legrand JC, et al. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res 1983; 268: 167–170
- 40 Tabaton M, Schenone A, Romagnoli P, Mancardi GL. A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. Acta Neuropathol (Berl) 1985; 68: 218–223
- 41 Mann DMA, Yates PO, Marcyniuk B. Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. J Neurol Neurosurg Psychiatry 1987; 50: 341–344
- 42 German DC, White CL, Sparkman DR. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cortex. Neuroscience 1987; 21: 305–312
- 43 Nakashima S, Ikuta F. Catecholamine neurons with Alzheimer's neurofibrillary changes and alteration of tyrosine hydroxylase. Immunohistochemical investigation of tyrosine hydroxylase. Acta Neuropathol (Berl) 1985; 66: 37–41
- 44 Tomlinson BE, Irving D, Blessed G. Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci 1981; 49: 419–428
- 45 Bondareff W, Mountjoy CQ, Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982; 32: 164–168
- 46 Iversen LL, Rossor MN, Reynolds GP, et al. Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett 1983; 39: 95–100
- 47 Marcyniuk B, Mann DMA, Yates PO. The topography of cell loss from locus caeruleus in Alzheimer's disease. J Neurol Sci 1986; 76: 335–345
- 48 Yamamoto T, Hirano A. Nucleus raphe dorsalis in Alzheimer's disease. Neurofibrillary tangles and loss of neurons. Ann Neurol 1985; 17: 573–577
- 49 Zweig RM, Ross CA, Hedreen JC, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1988; 24: 233–242
- 50 Burke WJ, Chung HD, Huang JS, et al. Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease. Ann Neurol 1988; 24: 532–536
- 51 Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745–752
- 52 Ohama E, Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol (Berl) 1976; 34: 311–319